Foyston Gordon & Payne Inc lowered its stake in shares of Relx Plc (NYSE:RELX – Get Rating) by 6.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 72,304 shares of the technology company’s stock after selling 5,233 shares during the quarter. Foyston Gordon & Payne Inc’s holdings in Relx were worth $2,358,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in RELX. UMB Bank N A MO bought a new position in shares of Relx during the 4th quarter valued at $38,000. Fieldpoint Private Securities LLC raised its position in Relx by 21.7% in the fourth quarter. Fieldpoint Private Securities LLC now owns 1,961 shares of the technology company’s stock worth $64,000 after acquiring an additional 350 shares during the period. Assetmark Inc. boosted its stake in shares of Relx by 17.6% during the 3rd quarter. Assetmark Inc. now owns 3,235 shares of the technology company’s stock worth $93,000 after acquiring an additional 485 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of Relx by 23.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,284 shares of the technology company’s stock valued at $107,000 after acquiring an additional 613 shares during the period. Finally, FMR LLC increased its stake in shares of Relx by 10.9% in the 1st quarter. FMR LLC now owns 5,058 shares of the technology company’s stock worth $108,000 after purchasing an additional 498 shares in the last quarter. Institutional investors own 13.56% of the company’s stock.
RELX has been the subject of several recent research reports. Credit Suisse Group boosted their price target on Relx from GBX 2,600 ($32.05) to GBX 2,650 ($32.67) in a report on Tuesday, March 29th. StockNews.com initiated coverage on shares of Relx in a research report on Saturday, May 14th. They set a “buy” rating on the stock. Zacks Investment Research lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Thursday, March 24th. The Goldman Sachs Group assumed coverage on shares of Relx in a report on Thursday, January 20th. They issued a “buy” rating on the stock. Finally, Morgan Stanley dropped their price objective on shares of Relx from GBX 2,750 ($33.90) to GBX 2,730 ($33.65) in a report on Thursday, February 17th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $1,804.67.
About Relx (Get Rating)
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk.
- Get a free copy of the StockNews.com research report on Relx (RELX)
- The Institutional Tide Has Turned For Cisco Systems
- Don’t Bet On Cheaper Oil, Not Yet Anway
- Can Nvidia Bounce Back
- A Reversal In The S&P 500 Is Confirmed
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.